SCHEMBL5010302

SCHEMBL5010302

O=CC1Oc2ccccc2O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.41
NTSR1 P30989 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.33
BLM P54132 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PARP1 P09874 1/20 0.32
ALDH1A1 P00352 2/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
ITGB2 P05107 1/20 0.32
ICAM1 P05362 1/20 0.32
ITGAL P20701 1/20 0.32
CYP2A6 P11509 1/20 0.32
HPGD P15428 1/20 0.32
HTT P42858 1/20 0.32
NISCH Q9Y2I1 2/20 0.31
MAOB P27338 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6265801 0.75 NISCH (0.49) CA2LMNAHPGDNISCHMAOB
SCHEMBL5804269 0.74 NISCH (0.35) CA2MEN1KMT2AABCG2ITGB2
SCHEMBL5804265 0.74 CA2 (0.32) CA2ABCG2ITGB2ICAM1ITGAL
SCHEMBL3639080 0.74 NISCH (0.35) CA2PARP1ABCG2ITGB2ICAM1
SCHEMBL7765718 0.74 CA2 (0.32) CA2ABCG2ITGB2ICAM1ITGAL
SCHEMBL7765721 0.74 HRH3 (0.34) CA2ALDH1A1ABCG2ITGB2ICAM1
SCHEMBL3394611 0.70 CA2 (0.42) CA2NTSR1GPR55PARP1ALDH1A1
SCHEMBL3652062 0.70 CA2 (0.31) CA2
SCHEMBL7777038 0.70 CA2 (0.31) CA2PARP1
SCHEMBL31531605 0.70 CA2 (0.42) CA2NTSR1GPR55PARP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0537517-B1 Method for the preparation of 2,2-difluorobenzo(1,3)dioxolecarbaldehydes and intermediates BAYER AG (DE) 1997-01-22 EP claimed
US-5420308-A 2,2-difluorobenzo (1,3)-dioxole-carbaldehydes and new intermediate products BAYER AKTIENGESELLSCHAFT (DE) 1995-05-30 US claimed
EP-0537517-A1 Method for the preparation of 2,2-difluorobenzo(1,3)dioxolecarbaldehydes and intermediates BAYER AG (DE) 1993-04-21 EP claimed
JP-5194478-A None JP disclosed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US disclosed
US-20230151305-A1 FRAGRANCE COMPOSITION SA, GIVAUDAN (CH) 2023-05-18 US disclosed
CN-111187148-B Method for simultaneously preparing o-hydroxy phenetole and 1, 3-benzodioxole-2-one 上海大学 2022-08-09 CN disclosed
CN-111187148-B Method for simultaneously preparing o-hydroxy phenetole and 1, 3-benzodioxole-2-one 上海大学 2022-08-09 CN disclosed
CN-111187148-A Method for simultaneously preparing o-hydroxy phenetole and 1, 3-benzodioxole-2-one 上海大学 2020-05-22 CN disclosed
CN-111187148-A Method for simultaneously preparing o-hydroxy phenetole and 1, 3-benzodioxole-2-one 上海大学 2020-05-22 CN disclosed
CN-106957317-B Novel pyrazole derivatives 持田制药株式会社 2019-12-31 CN disclosed
EP-0537517-B1 Method for the preparation of 2,2-difluorobenzo(1,3)dioxolecarbaldehydes and intermediates BAYER AG (DE) 1997-01-22 EP disclosed
US-5525739-A Process for the preparation of 2,2-difluorobenzo[1,3]-dioxole-carbaldehydes and new intermediate products BAYER AKTIENGESELLSCHAFT (DE) 1996-06-11 US disclosed
US-5525739-A Process for the preparation of 2,2-difluorobenzo[1,3]-dioxole-carbaldehydes and new intermediate products BAYER AKTIENGESELLSCHAFT (DE) 1996-06-11 US disclosed
US-5420308-A 2,2-difluorobenzo (1,3)-dioxole-carbaldehydes and new intermediate products BAYER AKTIENGESELLSCHAFT (DE) 1995-05-30 US disclosed
US-5420308-A 2,2-difluorobenzo (1,3)-dioxole-carbaldehydes and new intermediate products BAYER AKTIENGESELLSCHAFT (DE) 1995-05-30 US disclosed
JP-H05194478-A PRODUCTION OF 2,2-DIFLUOROBENZO(1,3)-DIOXYOLE-CARBALDEHYDE AND NEW INTERMEDIATE PRODUCT BAYER AG 1993-08-03 JP disclosed
EP-0537517-A1 Method for the preparation of 2,2-difluorobenzo(1,3)dioxolecarbaldehydes and intermediates BAYER AG (DE) 1993-04-21 EP disclosed
EP-0537517-A1 Method for the preparation of 2,2-difluorobenzo(1,3)dioxolecarbaldehydes and intermediates BAYER AG (DE) 1993-04-21 EP disclosed
US-4427666-A 3,5-Dihalogeno-1,2-methylenedioxybenzene arthropodicide synergizing agents BAYER AKTIENGESELLSCHAFT (DE) 1984-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 CA2 3795/4885NTSR1 1198/4885GPR55 222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.